pISSN 1226-6051
eISSN 2508-786X

Table. 5.

Table. 5.

List of drug classes for cost associated with drug loss prevention

Type of medications Drug loss prevention costs, KRW (%) Number of interventions (%)
Antineoplastic agents 26,276,839(70.4%) 38(15.3%)
Antimicrobial agents 2,628,731(7.1%) 67(26.9%)
Antivirals for systemic use 1,103,183(3.0%) 27(10.8%)
Antimycotics for systemic use 1,041,572(2.8%) 7(2.8%)
Antibacterials for systemic use 483,218(1.3%) 31(12.4%)
Antimycobacterials 758(0.0%) 2(0.8%)
Supportive care agents 8,360,188(22.4%) 91(36.5%)
Corticosteroids for systemic use 36,238(0.1%) 11(4.4%)
Blood substitutes and perfusion solutions 1,395,831(3.7%) 23(9.2%)
Drugs for acid related disorders 30,541(0.1%) 18(7.2%)
Immunostimulants 685,111(1.8%) 2(0.8%)
Antiepileptics 8,648(0.0%) 11(4.4%)
Immunosuppressants 4,899,310(13.1%) 7(2.8%)
All other therapeutic products 980,501(2.6%) 9(3.6%)
Antiemetics and antinauseants 115,484(0.3%) 5(2.0%)
Immune sera and immunoglobulins 206,197(0.6%) 1(0.4%)
Endocrine therapy 1,697(0.0%) 1(0.4%)
Antigout preparations 630(0.0%) 3(1.2%)
Other agents* 37,435(0.1%) 53(21.3%)
Total 37,303,192(100%) 249(100%)

*Psycholeptics, drugs for constipation, antidiarrheals, intestinal antiinflammatory/antiinfective agents, drugs for functional gastrointestinal disorders, lipid modifying agents, drugs used in diabetes, calcium channel blockers, analgesics, diuretics, mineral supplements, antianemic preparations, bile and liver therapy, vitamins, urologicals, antithrombotic agents, other nervous system drugs, antihistamines for systemic use, antihemorrhagics, general nutrients, vasoprotectives, throat preparations, ophthalmologicals, nasal preparations, digestives, incl. enzymes, cough and cold preparations, cardiac therapy, anti-parkinson drugs, antiinflammatory and antirheumatic products, antifungals for dermatological use, agents acting on the renin-angiotensin system

Korean J Clin Pharm 2022;32:215-25 https://doi.org/10.24304/kjcp.2022.32.3.215
© 2022 Korean J Clin Pharm